Relapse or Reinfection After Failing Hepatitis C Direct Acting Antiviral Treatment: Unravelled by Phylogenetic Analysis

PLoS ONE - United States
doi 10.1371/journal.pone.0201268
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Oral Direct-Acting Antiviral Therapy for Hepatitis C

Journal of Antivirals & Antiretrovirals
2012English

Treatment of the Chronic Hepatitis C Complicated by Mixed Cryoglobulinemia With Direct-Acting Antiviral Agents

Jurnal Infektologii
Infectious Diseases
2018English

Predictors of Hepatocellular Carcinoma After Hepatitis C Virus Eradication Following Direct-Acting Antiviral Treatment: Relationship With Serum Zinc

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2020English

Direct-Acting Antiviral Drugs and Hepatitis C Virus: A Therapeutic Revolution?

Cancer
Cancer ResearchOncology
2015English

Direct‐Acting Antiviral Treatment of Patients With Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis

Hepatology Communications
Hepatology
2019English

Persistent Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Following Virus Eradication After Direct-Acting Antiviral Therapy

Hepatology
MedicineHepatology
2017English

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Digestive Diseases and Sciences
PhysiologyGastroenterology
2011English

Two Cases of Hepatocellular Carcinoma Occurring Immediately After Direct-Acting Antiviral Agents Against Hepatitis C Virus

Internal Medicine
Internal MedicineMedicine
2019English

Concerns About Direct-Acting Antiviral Agents for Hepatitis C—Cause for Reassurance

JAMA network open
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy